Disclaimer

Use of Creo products in consumer packaged goods may be regulated by the Food and Drug Administration (“FDA”). The products offered for sale by Creo have not been approved for a specific purpose by the FDA nor have any of the statements contained herein been evaluated for safety or efficacy by the FDA. The products sold by Creo are not intended to diagnose, treat, cure or prevent any disease. Creo has provided research materials pertaining to cannabigerol (“CBG”) solely to provide the reader with information on the types of studies being conducted on CBG and/or other cannabinoids.

Creo makes no representation as to the accuracy or validity of the research referenced herein or as to the safety or validity of any conclusions drawn by any studies referenced herein. Such studies may or may not be peer-reviewed and may have not been reviewed by the FDA. Any quoted excerpts provided herein may not be an accurate summary of the research contained in the referenced study and are merely included to indicate that some research is being conducted with respect to cannabinoids and the referenced subject. Readers should read the entire study in order to draw their own conclusions regarding the validity of such study.

Any customer of Creo that desires to use Creo’s products should not make any claims regarding the effectiveness of such products in diagnosing, treating, curing or preventing any disease or medical condition unless such customer has independently received approval from the FDA to make such claims.

© All rights reserved, Creo 2020